510(k) · Cleared
ClearedAspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Corgenix, Inc. · OBW 11-Dehydro Thromboxane B2 Kit, Urinary
Cleared on May 29, 2007 as substantially equivalent to K042423 (Accumetrics, Inc., 2004) after a 315-day review. Its family tree reaches back 2 generations to 1983.
- Decided
- May 29, 2007
- Review
- 315 days
- Class
- Class II
- Product code
- OBW
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K830749 (1983). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K042423 | Verifynow-Aspirin AssaySummary page 1…ification: 21 CFR 864 5700 Proposed Product Code: jo 0z L Predicate Device: VerifyNow~"' Aspirin Assay (K042423) Device Description: An ELISA for the detection of urinary 1I1-Dehydro Thromboxane B2 (I1 dhTxB 2). Goat anti-mouse IgG polyclon… | 2004 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 21.4 years on median.
- None of the 2 ancestors has a recall.
- 1 other device also cites its predicate K042423.
How does its category compare?
All OBW devicesOBW 11-Dehydro Thromboxane B2 Kit, Urinary: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · OBW
1in 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · OBW
Too few OBW 510(k)s in any year since 2007 to give a median.
Recalls per year · OBW
No recall names OBW since 2007.
Adverse event reports per year · OBW
2in 2023
MAUDE reports naming product code OBW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 3 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 2 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B 2 (I1 dhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only. The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories. The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine…
Read the full statement (110 words)
The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B 2 (I1 dhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.
The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories.
The AspirinWorks® Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B2 (1ldhTxB 2) in human urine, which aids in the qualitative detection of aspirin effect in apparently healthy individuals post ingestion. For professional use only.
The AspirinWorks® Test Kit is intended for use in clinical (hospital and reference) laboratories.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K062025 · printed Nov 6, 2026
Cite this page
510(k) Report. “K062025: Aspirinworks Test Kit (11-Dehydro Thromboxane B2), Model 12136.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062025
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026